학술논문
467P Monocyte to red blood cells ratio (MRR): an innovative haematologic prognostic parameter in FOLFIRI-aflibercept treated patients: A subgroup analysis from the DISTINCTIVE trial
Document Type
Abstract
Author
Source
In Annals of Oncology September 2021 32 Supplement 5:S565-S565
Subject
Language
ISSN
0923-7534